Pharmaceutical Preparations - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Pharmaceutical industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Pharmaceutical Preparations - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Pharmaceutical Preparations
Corporate Insider Buy Sell Ratio (Insider Count) - Pharmaceutical Preparations
Pharmaceutical Preparations - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2026-02-03 PULM / Pulmatrix, Inc. 4 Higgins Michael J A - Award D 8,800
2025-12-09 RZLT / Rezolute, Inc. 4 Evans Daron P - Purchase D 5.04 10,549
2025-09-23 CYTK / Cytokinetics, Incorporated 4 Malik Fady Ibraham S - Sale D 49.28 -2,000
2025-09-23 ROIV / Roivant Sciences Ltd. 4 Venker Eric S - Sale D 14.83 -611,000
2025-09-23 CYTK / Cytokinetics, Incorporated 4 Malik Fady Ibraham M - Exercise D 10.60 2,000
2025-09-22 SUPN / Supernus Pharmaceuticals, Inc. 4 Khattar Jack A. S - Sale D 47.02 -16,587
2025-09-22 ABEO / Abeona Therapeutics Inc. 4 O'Malley Brendan M. S - Sale D 5.43 -688
2025-09-22 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 417.8875 -2,000
2025-09-22 ROIV / Roivant Sciences Ltd. 4 Venker Eric S - Sale D 14.99 -316,182
2025-09-22 ROIV / Roivant Sciences Ltd. 4 Venker Eric S - Sale D 15.01 -100,000
2025-09-22 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 416.7188 -2,000
2025-09-22 RNA / Avidity Biosciences, Inc. 4 Hughes Steven George S - Sale D 40.58 -2,208
2025-09-22 AXSM / Axsome Therapeutics, Inc. 4 Jacobson Mark L. S - Sale D 115.96 -10,000
2025-09-22 XOMA / XOMA Royalty Corporation 4 BURNS THOMAS M. S - Sale D 36.81 -15
2025-09-22 XOMA / XOMA Royalty Corporation 4 BURNS THOMAS M. S - Sale D 35.98 -4,300
2025-09-22 XOMA / XOMA Royalty Corporation 4 BURNS THOMAS M. S - Sale D 36.93 -15
2025-09-22 SAVA / Cassava Sciences, Inc. 4 Barry Richard By Trust P - Purchase I 2.28 7,172
2025-09-22 AXSM / Axsome Therapeutics, Inc. 4 Jacobson Mark L. M - Exercise D 2.85 10,000
2025-09-22 RNA / Avidity Biosciences, Inc. 4 Hughes Steven George M - Exercise D 10.16 2,208
2025-09-22 ROIV / Roivant Sciences Ltd. 4 Venker Eric M - Exercise D 3.85 462,374
2025-09-22 SUPN / Supernus Pharmaceuticals, Inc. 4 Khattar Jack A. M - Exercise D 12.98 27,060
2025-09-22 ROIV / Roivant Sciences Ltd. 4 Venker Eric M - Exercise D 3.85 100,000
2025-09-22 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A M - Exercise D 120.26 4,000
2025-09-22 ALZN / Alzamend Neuro, Inc. 4 AULT MILTON C III By Ault Lending, LLC C - Conversion I 2.32 100,000
2025-09-21 RFL / Rafael Holdings, Inc. 4 Polinsky David F - Taxes D 1.49 -1,970
2025-09-20 ROIV / Roivant Sciences Ltd. 4 Pulik Richard F - Taxes D 15.04 -2,129
2025-09-19 RCKT / Rocket Pharmaceuticals, Inc. 4 RTW INVESTMENTS, LP X - Other I 17.8112 59,000
2025-09-19 RCKT / Rocket Pharmaceuticals, Inc. 4 RTW INVESTMENTS, LP X - Other I 19.0916 41,000
2025-09-19 RCKT / Rocket Pharmaceuticals, Inc. 4 RTW INVESTMENTS, LP X - Other I 40.0324 1,000,000
2025-09-19 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 411.0775 -4,000
2025-09-19 BYSI / BeyondSpring Inc. 4 Decheng Capital China Life Sciences USD Fund III, L.P. By Decheng Capital China Life Sciences USD Fund III, L.P. S - Sale I 1.79 -3,656
2025-09-19 ROIV / Roivant Sciences Ltd. 4 Venker Eric S - Sale D 14.95 -683,818
2025-09-19 ELVN / Enliven Therapeutics, Inc. 4 Kintz Samuel S - Sale I 20.25 -1,000
2025-09-19 ELVN / Enliven Therapeutics, Inc. 4 Lyssikatos Joseph P S - Sale I 20.016 -2,130
2025-09-19 AQST / Aquestive Therapeutics, Inc. 4 Barber Daniel S - Sale D 6.00 -400
2025-09-19 UTHR / United Therapeutics Corporation 4 Olian Judy D. S - Sale D 415.4266 -1,800
2025-09-19 LLY / Eli Lilly and Company 4 LILLY ENDOWMENT INC S - Sale D 763.053 -22,965
2025-09-19 ELVN / Enliven Therapeutics, Inc. 4 Lyssikatos Joseph P S - Sale I 19.1095 -4,870
2025-09-19 LLY / Eli Lilly and Company 4 LILLY ENDOWMENT INC S - Sale D 764.473 -700
2025-09-19 LVTX / LAVA Therapeutics N.V. 4 Versant Venture Capital VI, L.P. S - Sale D 1.4014 -2,370,533
2025-09-19 LVTX / LAVA Therapeutics N.V. 4 Versant Venture Capital VI, L.P. S - Sale I 1.4014 -532,870
2025-09-19 ALZN / Alzamend Neuro, Inc. 4 AULT MILTON C III By Ault Lending, LLC S - Sale I 2.3485 -77,009
2025-09-19 ANIP / ANI Pharmaceuticals, Inc. 4 Davis Krista S - Sale D 98.04 -1,000
2025-09-19 APLS / Apellis Pharmaceuticals, Inc. 4 Dunlop A. Sinclair Indirect Owner (Epidarex) S - Sale I 22.95 -31,092
2025-09-19 PGEN / Precigen, Inc. 4 KIRK RANDAL J by Kapital Joe S - Sale I 3.68 -3,596,892
2025-09-19 SAVA / Cassava Sciences, Inc. 4 Barry Richard By Trust P - Purchase I 2.25 400
2025-09-19 SAVA / Cassava Sciences, Inc. 4 Barry Richard By Trust P - Purchase I 2.29 46,908
2025-09-19 ROIV / Roivant Sciences Ltd. 4 Venker Eric M - Exercise D 3.85 1,000,000
2025-09-19 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A M - Exercise D 120.26 4,000
2025-09-19 XOMA / XOMA Royalty Corporation 4 Sitko Bradley M - Exercise D 6,712
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)